InvestorsHub Logo
Followers 31
Posts 388
Boards Moderated 0
Alias Born 03/12/2012

Re: BigJuan post# 10840

Sunday, 10/28/2012 1:37:29 PM

Sunday, October 28, 2012 1:37:29 PM

Post# of 27492
actually because I have been too busy to delete my mail I do have a copy... from Sept 27th... this is it... makes sense they would want to redeem themselves for this...

Hi Everyone,
PRTN had a stable trading day yesterday but we believe that a major upswing is about to happen in the next coming days. Why?

The end of the month is only a few days away and if history repeats itself there is a couple of factors that will help propel PRTN to a new all time high:

#1- A hard mailer campaign that will attract millions of potential new investors to PRTN which could lead to a huge upswing. We've seen this many time in the past, where picks go well over $3.00-$4.00 based on similar campaign.

#2- An on going effort from the Company to update its shareholders with weekly news. Any positive updates on their FDA approval process could send the stock crazy. Many bio-tech related stocks saw upswing of 100%-200% recently on positive feedback on their drugs even without an FDA approval.

#3- The end of month has shown to create massive short covering from institutions that are closing their books by month end. We've been watching the reg sho list and we believe that there could be sizeable short position that will be covered on PRTN soon.

If you look back at our previous picks, most of them saw massive gains of 300%-700% that started toward the end of a month!

PRTN could impress our members with massive gains in the coming days. We urge our members to be patient and to stand strong. We believe that everyone could reap the benefit very soon as the company continues to develop its operations.

If you missed the company's recent release here's an important excerpt from it:

In 2010, the women's health therapeutics market was calculated to be worth approximately $14.5 billion. GBI Research, a leading business intelligence provider, forecasts the market to grow at a Compound Annual Growth Rate (CAGR) of 7.9% between 2010 and 2017 to record a sales value of approximately $24.7 billion in 2017. Novel non-hormonal therapeutics such as Tropine 3 are expected to become increasingly popular during the forecast period. Based on current and expected market conditions, the Company estimates that Tropine 3, if successfully tested and promoted, has a global market potential in excess of $500 million in annual sales.

This clearly shows how big the market is for the company, If PRTN can achieve only 10% of that potential annual sales, the company could be worth well over $3.00!

Get ready to jump on PRTN if you believe in the company as much as we do. We believe the train is about to take off and wouldn’t want any of our members to miss out.

If you want to BUY PRTN, now is the time to do so before it starts making a move over $1-$2. We’ve seen it many times before with other stocks, and this could happen again in a heartbeat!


Happy Trading!
Your AwesomePennyStocks Editor.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.